Literature DB >> 3379053

Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme.

M Nakanishi1, J L Goldstein, M S Brown.   

Abstract

The enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) is subject to multivalent feedback suppression mediated by sterols and non-sterol substances derived from mevalonate, the product of the enzyme. To dissect the mechanism for this multivalent effect, Chinese hamster ovary cells were incubated with sterols contained in plasma lipoproteins and with a high concentration (100 microM) of compactin, an inhibitor of the reductase. Under these conditions, the amounts of HMG-CoA reductase protein and catalytic activity were high, although the cells were saturated with sterols, as reflected by active synthesis of cholesteryl esters. The amount of enzyme fell by 99% when the cells received excess mevalonate in addition to sterols. This decline was not associated with a fall in levels of reductase messenger RNA (mRNA). Rather, it was attributable to an 80% decline in translation of the mRNA, coupled with a 5-fold increase in the rate of degradation of reductase protein, as revealed by pulse-chase experiments with [35S]methionine. Considered together with previous data, these findings suggest a multilevel mechanism for multivalent regulation of HMG-CoA reductase. We suggest that sterols suppress the enzyme incompletely by partially repressing transcription of the gene and that nonsterol products derived from mevalonate further reduce the enzyme by inhibiting translation of the mRNA. Sterols and non-sterol products, acting together, accelerate the degradation of reductase protein. This combination of transcriptional and posttranscriptional controls can regulate the amount of reductase protein over a several hundred-fold range in animal cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Characterization and regulation of Leishmania major 3-hydroxy-3-methylglutaryl-CoA reductase.

Authors:  A Montalvetti; J Peña-Díaz; R Hurtado; L M Ruiz-Pérez; D González-Pacanowska
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

2.  In vivo action of the HRD ubiquitin ligase complex: mechanisms of endoplasmic reticulum quality control and sterol regulation.

Authors:  R G Gardner; A G Shearer; R Y Hampton
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

Review 3.  Innovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis Pathway.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Claudia Loganes; Liza Vecchi Brumatti; Alessandra Knowles; Sabrine Bilel; Alberto Tommasini; Roberta Bortul; Marina Zweyer
Journal:  Int J Mol Sci       Date:  2015-12-30       Impact factor: 5.923

Review 4.  Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials.

Authors:  Amirhossein Sahebkar; Luis E Simental-Mendía; Claudio Pedone; Gianna Ferretti; Petr Nachtigal; Simona Bo; Giuseppe Derosa; Pamela Maffioli; Gerald F Watts
Journal:  Br J Clin Pharmacol       Date:  2016-02-02       Impact factor: 4.335

5.  Effect of lovastatin on acyl-CoA: cholesterol O-acyltransferase (ACAT) activity and the basolateral-membrane secretion of newly synthesized lipids by CaCo-2 cells.

Authors:  N T Kam; E Albright; S Mathur; F J Field
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

6.  Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.

Authors:  Jesus A Villanueva; Anna Sokalska; Amanda B Cress; Israel Ortega; Kaylon L Bruner-Tran; Kevin G Osteen; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

7.  Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins.

Authors:  Luke J Engelking; Guosheng Liang; Robert E Hammer; Kiyosumi Takaishi; Hiroshi Kuriyama; Bret M Evers; Wei-Ping Li; Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

8.  Cationic modulation of rho 1-type gamma-aminobutyrate receptors expressed in Xenopus oocytes.

Authors:  D J Calvo; A E Vazquez; R Miledi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment.

Authors:  Vikram B Wali; Sunitha V Bachawal; Paul W Sylvester
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

10.  Methyl farnesoate synthesis in the lobster mandibular organ: the roles of HMG-CoA reductase and farnesoic acid O-methyltransferase.

Authors:  Sheng Li; Jon A Friesen; Kenneth C Holford; David W Borst
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2009-09-22       Impact factor: 2.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.